TCL Archive Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology April 5, 2002
TCL Archive FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines March 12, 1976
TCL Archive DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions October 24, 1980
TCL Archive Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?” October 3, 2014